NIFTY
37.05  0.36%
 10397.45
S&P BSE SENSEX
141.27  0.42%
 33844.86
Sun Pharmaceutical Industries Ltd.
NSE : SUNPHARMA BSE : 524715 ISIN code : INE044A01036
on 21-Feb-2018
NSE
-33.75    -6.03%
Rs. 525.75
 
Days Low
Rs. 511.45
Days High
Rs. 563

Open Rs. 559.4
 
52 week Low
Rs. 433.15
52 week High
Rs.728.45
 
 
Bid :                 0.00 (0)
Offer :        524.75 (8452)
BSE
Rs.524.75
-34.65    -6.19%
on 21-Feb-2018
BSE
-34.65    -6.19%
Rs. 524.75
 
Days Low
Rs. 511.3
Days High
Rs. 563

Open Rs. 560.05
 
52 week Low
Rs. 432.7
52 week High
Rs.729.05
 
 
Bid :                 0.00 (0)
Offer :        524.75 (8452)
NSE
Rs.525.75
-33.75    -6.03%
 
 
Last Price (Rs.)  524.75 Value  2221946335.00
Net Change (Rs.)  -34.65 Best Buy  0.00
Volume  4209528 Best Sell  524.75
Prev.Close (Rs.)  559.40 Best Quantity  0
Open (Rs.)  559.40 Sell Quantity  8452
High (Rs.)  563.00 52-Week High (Rs.)  728.45
Low (Rs.)  511.45 52-Week Low (Rs.)  433.15
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  1259044.84
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital2399.30 2406.60 2071.20 
Share Capital2399.30 2406.60 2071.20 
Share Capital2399.30 2406.60 2071.20 
Share Capital2399.30 2406.60 2071.20 
Share Capital2399.30 2406.60 2071.20 
Currents Investments400.10 735.60 939.30 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Cipla 596.85 480523 172.31 49.25 0.34
Piramal Enterprises 2633.35 474795 879.41 58.50 0.79
Cadila Healthcare 410.95 420707 73.15 63.58 0.78
Lupin 812.90 367477 342.26 11.69 0.92
Ranbaxy Labs. 859.90 366028 1.53 0.00 0.00
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Dec 2017Sep 2017Jun 2017
Net Sales20452.3018238.4018025.20
Operating Profit2117.908082.90-1470.20
PBDT1470.906787.10-11809.60
Net Profit405.005770.50-12909.90
More> 
 
Company News
2/20/2018 12:00:00 AM
Sun Pharma’s arm hikes stake in Ranbaxy Malaysia
2/20/2018 12:00:00 AM
Sun Pharma rises with arm hiking stake in Ranbaxy Malaysia
2/15/2018 12:00:00 AM
Sun Pharmaceutical slips on reporting 75% fall in Q3 consolidated net ...
More>
 
Ratios
   Earnings Per Share (Rs)-0.15 
   Book NAV/Share(Rs)86.98 
   PAT Margin (%)-0.45 
   Asset Turnover(x)0.23 
   PER(x)0.00 
   Yield(%)0.51 
   EV/Core EBITDA(x)280.28 
   M Cap / Sales21.44 
   Net Sales Growth(%)-0.46 
   PAT Growth(%)96.79 
   Total Debt/Equity(x)0.29 
   Current Ratio(x)0.58 
   Quick Ratio(x)0.37 
   Total Debt/Mcap(x)0.04 
More>